Lv31
238 积分 2022-07-12 加入
NQO1-responsive Trimethyl lock benzoquinone: A cleavable linker strategy for antibody-drug conjugates
22天前
已完结
Phase II Study of Intravenous DX‐8951f in Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane, and Topotecan
28天前
已完结
DX‐8951f: Summary of Phase I Clinical Trials
28天前
已完结
Chemo-biocatalytic regioselective one-pot synthesis of different deprotected monosaccharides
28天前
已完结
Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
1个月前
已完结
Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma
1个月前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
1个月前
已完结
NAD(P)H: quinone oxidoreductase 1 activatable toll-like receptor 7/8 agonist designed for precise immunotherapy
1个月前
已完结
Antibody–Drug Conjugates with Pyrrole‐Based KSP Inhibitors as the Payload Class
1个月前
已完结
Tailored Linker Chemistries for the Efficient and Selective Activation of ADCs with KSPi Payloads
1个月前
已完结
皖公网安备34019202002308
